Thalidomide-4-NH-C7-COO(t-Bu)

Thalidomide-4-NH-C7-COO(t-Bu) structure

CAS No.: 2226139-39-3

Chemical Name:: Thalidomide-4-NH-C7-COO(t-Bu)

Synonyms: Thalidomide-4-NH-C7-COO(t-Bu);2-(2,6-Dioxohexahydropyridin-3-yl)-4-(octylamino)isoindole-1,3-dione;tert-butyl 8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octanoate;Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester

CBNumber:: CB413888925

Molecular Formula:: C25H33N3O6

Molecular Weight:: 471.55

MDL Number:

MOL File:: 2226139-39-3.mol

Last updated:2025-05-19 13:47:41

Request For Quotation

Thalidomide-4-NH-C7-COO(t-Bu) Properties

Boiling point	665.374±55.00 °C(Press: 760.00 Torr)(predicted)
Density	1.253±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka	10.748±0.40(predicted)

Thalidomide-4-NH-C7-COO(t-Bu) Preparation Products And Raw materials

Raw materials

Preparation Products

Thalidomide-4-NH-C7-COO(t-Bu) Suppliers

Global( 3)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Jilin Chinese Academy of Sciences-yanshen Technology	+undefined18143011203	info@chemextension.com	China	42056	58
Daicel Chiral Technologies (China)CO.,LTD	021-50460086-9 15921403865	han_yajun@dctc.daicel.com	China	6576	65
Jilin Chinese Academy of Sciences-yanshen Technology	18143011203	ET-market@chemextension.com	China	27810	58

Supplier	Advantage
Jilin Chinese Academy of Sciences-yanshen Technology	58
Daicel Chiral Technologies (China)CO.,LTD	65
Jilin Chinese Academy of Sciences-yanshen Technology	58

2226139-39-3(Thalidomide-4-NH-C7-COO(t-Bu))Related Search:

tert-butyl (5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentyl)carbamate Thalidomide Thalidomide-4-NH-C7-NH-Boc Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester Thalidomide-4-O-C3-NHBoc

3-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)propanoic acid Thalidomide-4-NH-C9-NH-Boc Propanoic acid, 3-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]-, 1,1-dimethylethyl ester 5-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione, Hexanoic acid, 6-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester

Nonanoic acid, 9-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-, 1,1-dimethylethyl ester 6-Bromo-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)hexanamide

1of3

Thalidomide-4-NH-C7-COO(t-Bu) tert-butyl 8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octanoate 2-(2,6-Dioxohexahydropyridin-3-yl)-4-(octylamino)isoindole-1,3-dione Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester 2226139-39-3